The N-and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity
By binding to T cell (1)g mucin-3 (Tim-3) expressed on different cells,galectin-9 (Gal-9) mediates two important functions,triggering T cell death and activating innate immune cells.The mechanisms by which ligation of the same molecule on different cell types mediates different effects are largely unclear.Gal-9 contains two carbohydrate recognition domains (CRD) in the N-and C-terminal regions (Gal-9-N and Gal-9-c).The N and C terminals of Gal-9 have been shown to have different activities in promoting T cell death.However,whether the differences between two domains account for its dual functions remains to be elucidated.Here we hypothesized that the different functions of Gal-9 in innate immunity and adaptive immunity are mediated by different domains,To test this,we created recombinant Gal-9 (Gal-9-NC) and homodimers containing either the NCRD (Gal-9-N) or the CCRD (Gal-9-C).All these Gal-9 constructs can activate dendritic cells (DCs) and induce T cell death.However,the Gal-9-C was much more potent than the Gal-9-N in inducing T cell death,while the Gal-9-N was much more effective in activating DCs by inducing much higher TNF-α and IL-6 production,greater phosphorylation of p38 and AKT.in both DC and T cells,Gal-9-N but not Gal-9-C stimulation resulted in markedly iκBα degradation.Finally,computer analyses suggested different patterns and affinities for the binding of the Gal-9-N and Gal-9-C to their receptor,Tim-3.Our data suggest that the N-and C-terminal CRDs of Gal-9 contribute differently to its ability to induce T cell death and to activate DCs.Further investigations on the underlying mechanisms will provide new insights into the biochemical basis for the multiple activities of Gal-9.
Galectin-9 CRD Innate immunity Adaptive immunity
Yurong Li Hui Peng Gencheng Han Beifen Shen Yan Li Jiannan Feng Shaoxia Geng Shusheng Geng Huawei Wei Guojiang Chen Xinying Li Liyan Wang Renxi Wang
Department of Molecular Immunology, Institute of Basic Medical Sciences,Beijing 100850, China Department of Molecular Immunology, Institute of Basic Medical Sciences,Beijing 100850, China ; Inst Beijing Tian Guang Shi Biorech Corp.Ltd.Beijing Economic-Technological Development Area, Beijing 100
国际会议
南京
英文
497-504
2012-05-13(万方平台首次上网日期,不代表论文的发表时间)